Evidence map›Paper›PMID 41580864›Full record

ReviewCritical care (London, England)2026

Ultrafiltration in the critically ill patient: a framework for personalized care.

Paulo Melo, Gonzalo Ramírez-Guerrero, Ricardo Castro, Adrian Wong, Eduardo R Argaiz, Marlies Ostermann, Glenn Hernández, Eduardo Kattan

Registry-linked trialAbstract readReview
In one paragraph

Review in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07643597 (Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07643597 recruitingnot on this map

Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients

TypeobservationalSponsorHospital Las HiguerasRan2026 to 2027Enrolled128ConditionsAcute Kidney Injury, Fluid Overload, Fluid Overload in Dialysis Patients, Critical Illness
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paulo MeloIntensive Care Unit, Hospital Santiago Oriente Dr. Luis Tisné Brousse, Santiago, Chile.
Gonzalo Ramírez-GuerreroNephrology Service, Hospital Las Higueras, Talcahuano, Chile.
Ricardo CastroDepartamento de Medicina Intensiva, Facultad de Medicina, Pontificia Universidad Católica de Chile, Avenida Diagonal Paraguay 362, Santiago, Chile.
Adrian WongDepartment of Critical Care, King's College Hospital NHS Foundation Trust, London, UK.
Eduardo R ArgaizEscuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Mexico City, Mexico.
Marlies OstermannDepartment of Critical Care, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Glenn HernándezDepartamento de Medicina Intensiva, Facultad de Medicina, Pontificia Universidad Católica de Chile, Avenida Diagonal Paraguay 362, Santiago, Chile.
Eduardo KattanDepartamento de Medicina Intensiva, Facultad de Medicina, Pontificia Universidad Católica de Chile, Avenida Diagonal Paraguay 362, Santiago, Chile. e.kattan@gmail.com.

Funding

Fondo Nacional de Desarrollo Científico y Tecnológico Grant Nº 1230475
6 · The paper itself

Abstract

Fluid overload is common after resuscitation in critically ill patients and is independently associated with unfavorable outcomes. Ultrafiltration (UF) during renal replacement therapy is a common strategy to reverse this condition. Nevertheless, the optimal timing, dose, and safety limits remain unclear. Observational studies suggest a U-shaped relationship between net UF rate and mortality, highlighting a narrow therapeutic window. Insufficient UF prolongs exposure to congestion, whereas excessive UF may precipitate hemodynamic instability and tissue hypoperfusion. This phenomenon, often labeled "UF intolerance", lacks a standardized definition and is frequently attributed to intravascular volume depletion alone, overlooking broader cardiovascular and autonomic mechanisms. This perspective synthesizes the physiological effects and cardiovascular response to ultrafiltration and reframes "ultrafiltration intolerance" as a multidimensional construct determined by four compensatory axes: vascular refilling, cardiac response, venoconstriction/venous capacitance, and systemic arteriolar resistance. We delineate how renal replacement therapy-related factors interact with underlying critical illness to impair these axes and precipitate tissue hypoperfusion. Building on this framework, we (i) argue for proactive, individualized ultrafiltration prescriptions; (ii) propose dynamic predictors that emulate fluid removal to reveal physiologic reserve (iii) outline pragmatic, bedside endotypes of ultrafiltration intolerance: preload dependence, cardiac dysfunction, decreased vascular tone, autonomic dysfunction, and impaired vascular refilling. We propose a holistic framework that emphasizes prevention over rescue and guides tailored ultrafiltration prescription based on endotypes. Ultrafiltration intolerance in critically ill patients is multifactorial and not solely a problem of volume depletion. A physiology-based, preventive, and personalized ultrafiltration strategy (anchored in dynamic testing, ultrasound-based congestion profiling, and perfusion monitoring) may improve hemodynamic tolerance, decongestion efficacy, and patient-centered outcomes. Prospective studies should validate these concepts to establish evidence-based protocols for personalized ultrafiltration in critical care.

Indexed as

Critical IllnessPrecision MedicineHemodynamicsHumansRenal Replacement TherapyUltrafiltrationCritical careDynamic predictorsEndotypesFluid overloadIntolerancePersonalizedUltrafiltration

Identifiers

PMID41580864
PMCPMC12915024

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.